Research Priorities for Malignant Pleural Organization with Loculation and Failed Drainage
Cells · 21.07.2025 · 14 (14) · 1118
DOI: 10.3390/cells14141118 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 21.07.2025. Verfasst von Torry A Tucker und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Biology, Center for Biomedical Research, School of Medicine, The University of Texas Health Science Center at Ty…. Hauptthemen laut MEDLINE: Pleural Effusion, Malignant, Drainage, Pleura. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, NIH.
Abstract (Originalsprache)
Malignant pleural effusion (MPE) can lead to pleural organization with loculation and impaired drainage. This condition is becoming increasingly more common due to advancements in cancer therapy and extended patient survival. Factors such as repeated thoracentesis through an indwelling pleural catheter (IPC), intrapleural bleeding, and tumor progression contribute to MPE organization. Loculated MPE causes breathlessness and reduced quality of life, and current therapies, including intrapleural fibrinolytic or enzymatic therapy (IPFT/IET), have limitations in efficacy and safety. Identifying new therapeutic targets is crucial for improving treatment outcomes. Research is needed to understand the role of profibrogenic factors in pleural neoplasia, their regulation, and their impact on different stages of pleural organization. The development of a rabbit model of organizing MPE could provide insights into underlying mechanisms and novel interventions. Comparative studies of pleural tissues and effusions from MPE patients and other forms of pleural organization may reveal valuable information. Cellular and molecular profiling, assessment of biomarkers, and personalized IPFT dosing are potential areas of investigation. Suppression of PAI-1 activity and the role of hyaluronic acid in malignant mesothelioma are also important research directions. Understanding the profibrogenic capacity of pleural mesothelial cells undergoing mesenchymal transition (MesoMT) and identifying key contributors and effectors involved in this process are essential for developing effective treatments for loculated MPE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cellular and Molecular Biology, Center for Biomedical Research, School of Medicine, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA.
ORCID-Profile: Torry A Tucker, Steven Idell
Förderung
- NHLBI NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Tucker, T. A., Massarelli, E., Destarac, L., & Idell, S. (2025). Research Priorities for Malignant Pleural Organization with Loculation and Failed Drainage. Cells, 14(14), 1118. https://doi.org/10.3390/cells14141118
Vancouver
Tucker TA, Massarelli E, Destarac L, Idell S. Research Priorities for Malignant Pleural Organization with Loculation and Failed Drainage. Cells. 2025;14(14):1118. doi:10.3390/cells14141118
BibTeX
@article{Tucker2025,
author = {Tucker, Torry A and Massarelli, Erminia and Destarac, Luis and Idell, Steven},
title = {Research Priorities for Malignant Pleural Organization with Loculation and Failed Drainage},
journal = {Cells},
year = {2025},
volume = {14},
number = {14},
pages = {1118},
doi = {10.3390/cells14141118}
}
EUVIMED